Samulski

AskBio Names Mansuo Shannon Chief Scientific Officer

Retrieved on: 
Tuesday, April 9, 2024
Eli Lilly, Alzheimer's disease, Gene editing, Princeton University, MIT, Research, Bayer, Chugai Pharmaceutical Co., Doctor of Philosophy, Samulski, Therapy, Eli Lilly and Company, CSO, Molecular biology, Management

Shannon joins AskBio from Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company

Key Points: 
  • Shannon joins AskBio from Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company
    Co-Founder and former Chief Scientific Officer R. Jude Samulski to remain member of AskBio Board of Directors
    Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, announced today that on April 8, 2024, Mansuo Shannon, PhD, was named the company’s next Chief Scientific Officer (CSO).
  • Shannon joins AskBio from Prevail Therapeutics, where she also served as CSO.
  • Reporting to Gustavo Pesquin, Chief Executive Officer (CEO), Shannon will be a member of AskBio’s Executive Leadership Team and head its R&D organization.
  • As part of her role as CSO at AskBio, Shannon will develop and implement the company’s future R&D strategy.

Mission Cloud Launches New Generative AI Podcast Hosted by Generative AI

Retrieved on: 
Thursday, October 19, 2023
Cloud, Samulski, Human, ChatGPT, Synthetic media, Amazon Web Services, Mission, Machine learning, Analytics, AWS, Noise, AI, Amazon, Customer service

LOS ANGELES, Oct. 19, 2023 /PRNewswire-PRWeb/ -- Mission Cloud, a US-based Amazon Web Services (AWS) Premier Tier Partner, today launched Mission: Generate, a new, innovative podcast cutting through the noise and helping businesses and technology professionals discover what's real and what's simply hype when it comes to the generative AI landscape. The podcast will feature hosts Dr. RyAIn Ries and CAIsey Samulski – AI versions of Mission Cloud's Dr. Ryan Ries, Practice Lead, Data, Analytics, AI & Machine Learning, and Casey Samulski, Sr. Product Marketing Manager – discussing real-world generative AI applications that drive business success and industry evolution.

Key Points: 
  • The podcast will feature hosts Dr. RyAIn Ries and CAIsey Samulski – AI versions of Mission Cloud's Dr. Ryan Ries, Practice Lead, Data, Analytics, AI & Machine Learning, and Casey Samulski, Sr.
  • Product Marketing Manager – discussing real-world generative AI applications that drive business success and industry evolution.
  • Generative AI was used to synthesize the conversations to create a generative AI podcast, by generative AI, about generative AI.
  • Episodes will explore real-world examples of how to strategically use and optimize generative AI to generate outputs, drive higher efficiency and debunk common misconceptions about the technology.

AskBio CSO Jude Samulski Named 2020 Business Person of the Year by Triangle Business Journal

Retrieved on: 
Friday, December 11, 2020
Samulski, Adeno-associated virus, Research Triangle, AAV, Economy of the United States, North Carolina, Regions of the United States

RESEARCH TRIANGLE PARK, N.C., Dec. 11, 2020 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today announced that its President and Chief Scientific Officer, Jude Samulski, PhD, has been honored as Triangle Business Journals (TBJ) 2020 Business Person of the Year.

Key Points: 
  • RESEARCH TRIANGLE PARK, N.C., Dec. 11, 2020 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today announced that its President and Chief Scientific Officer, Jude Samulski, PhD, has been honored as Triangle Business Journals (TBJ) 2020 Business Person of the Year.
  • TBJs Business Person of the Year award recognizes executives working in the Triangle area who have consistently driven business success while also demonstrating the power of corporate citizenry.
  • This was a particularly tough year for the Triangle Business Journal editorial team because there were so many deserving candidates, said Sougata Mukherjee, Editor-in-Chief of the Triangle Business Journal.
  • We are thrilled to have selected Jude Samulski as our 2020 TBJ Business Person of the Year after an arduous selection process that lasted almost two months.

AskBio CSO Jude Samulski Receives 2020 Life Sciences Award from the Triangle Business Journal

Retrieved on: 
Monday, August 24, 2020
Samulski, Adeno-associated virus, Branches of biology, R. Jude Samulski

RESEARCH TRIANGLE PARK, N.C., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today announced that its president and chief scientific officer, Jude Samulski, PhD, has been honored as one of the Triangle Business Journals (TBJ) 2020 Life Sciences Award winners.

Key Points: 
  • RESEARCH TRIANGLE PARK, N.C., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today announced that its president and chief scientific officer, Jude Samulski, PhD, has been honored as one of the Triangle Business Journals (TBJ) 2020 Life Sciences Award winners.
  • The award recognizes individuals and research organizations at the forefront of innovation in the growing Triangle-area life sciences industry, representing biotechnology, pharmaceuticals, clinical research, human health, medical devices and diagnostics.
  • Its an honor to be recognized as part of this esteemed group that is driving transformation and growth in our local life sciences industry, said Samulski.
  • This is the second recent accolade for Samulski, who was named one of PharmaVOICE Magazines Most Inspiring Leaders in Life Sciences earlier this month.

AskBio CSO Jude Samulski Named One of the Most Inspiring Leaders in Life Sciences by PharmaVOICE Magazine

Retrieved on: 
Monday, August 3, 2020
Business, Articles, Economy, Samulski, Entrepreneurship, Forward-looking statement

Highlighted in the Entrepreneurs category, Dr. Samulski is recognized by PharmaVOICE as a transformative leader in genetic medicine.

Key Points: 
  • Highlighted in the Entrepreneurs category, Dr. Samulski is recognized by PharmaVOICE as a transformative leader in genetic medicine.
  • Since co-founding AskBio in 2001, he has maintained an unwavering commitment to patients by creating and leading teams dedicated to challenging the status quo by pursuing new solutions.
  • I am humbled to be included among this list of outstanding leaders who are boldly changing the future of healthcare, said Dr. Samulski.
  • AskBio does not undertake any obligation to publicly update its forward-looking statements based on events or circumstances after the date hereof.